Drug intelligence / Profile preview

ImmunD

Development stage
Unknown
Lead developer
Indoco Remedies
Modality
Small Molecules
Administration
Oral
01

Overview

ImmunD is a pharmaceutical brand of cholecalciferol (Vitamin D3), a fat-soluble secosteroid essential for maintaining calcium and phosphate homeostasis. It is primarily indicated for the treatment and prevention of Vitamin D deficiency, osteoporosis, and related bone disorders. Cholecalciferol acts as a prohormone that is metabolically converted to its active form, calcitriol (1,25-dihydroxyvitamin D3), through sequential hydroxylations in the liver and kidneys. Calcitriol functions as a high-affinity ligand for the Vitamin D Receptor (VDR), a nuclear transcription factor. Upon activation, the VDR-calcitriol complex modulates the expression of genes involved in intestinal calcium absorption, renal calcium handling, and bone remodeling. Additionally, ImmunD plays a significant role in immune modulation by enhancing the antimicrobial activities of innate immune cells and regulating adaptive immune responses.

Brand names
ImmunD
Other names
cholecalciferolVitamin D3calciol
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on ImmunD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImmunD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call